Literature DB >> 1514177

Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study.

M Hoffman1, D M Monroe, H R Roberts.   

Abstract

Factor IX plays a central role in blood coagulation, since it can be activated by either XIa (intrinsic pathway) or tissue factor-VIIa (extrinsic pathway). Activated factor IX (IXa), in a surface-bound complex with factor VIIIa, then activates factor X. Platelets provide the catalytic surface upon which this Xase complex is assembled in vivo. We have used flow cytometry to examine binding of factor IXa to thrombin-activated platelets in the absence of added VIIIa. Platelet-bound IXa and platelet protein GPIb were detected by indirect immunofluorescence staining followed by two-color flow cytometric analysis. Microparticles were identified by their light scattering characteristics. Two binding sites for factor IXa were detected. The high affinity binding site saturated at about 10 nM, with a Kd of 1.6 nM. A second binding curve, with a Kd of about 100 nM, was observed at higher concentrations of IXa. The high affinity factor IXa binding sites comprise about 7% of the total factor IXa binding. Binding to both sites was dependent on the presence of calcium. Thus, we conclude that factor IXa, in addition to its high affinity binding, has a calcium-dependent low affinity association with activated platelets and microparticles. Sims et al, have shown that binding sites for a different coagulation factor, factor Va, are concentrated on microparticles relative to platelet membrane proteins, such as GPIb. GPIb is distributed on platelets and microparticle in proportion to plasma membrane surface.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514177

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

Review 1.  Function and clinical significance of platelet-derived microparticles.

Authors:  S Nomura
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

4.  Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes.

Authors:  Min-Dan Xu; Xian-Zheng Wu; Yun Zhou; Ying Xue; Ke-Qin Zhang
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

5.  Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.

Authors:  Matthew Duvernay; Summer Young; David Gailani; Jonathan Schoenecker; Heidi E Hamm; Heidi Hamm
Journal:  Mol Pharmacol       Date:  2013-01-10       Impact factor: 4.436

6.  Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.

Authors:  Ruzica Livaja Koshiar; Sofia Somajo; Eva Norström; Björn Dahlbäck
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

7.  Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation.

Authors:  Lluis Pujadas-Mestres; Irene Lopez-Vilchez; Eduardo Arellano-Rodrigo; Joan Carles Reverter; Antonio Lopez-Farre; Maribel Diaz-Ricart; Juan Jose Badimon; Gines Escolar
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

8.  Prognostic Value of Circulating Microvesicle Subpopulations in Ischemic Stroke and TIA.

Authors:  Annika Lundström; Fariborz Mobarrez; Elisabeth Rooth; Charlotte Thålin; Magnus von Arbin; Peter Henriksson; Bruna Gigante; Ann-Charlotte Laska; Håkan Wallén
Journal:  Transl Stroke Res       Date:  2020-01-25       Impact factor: 6.829

Review 9.  The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation.

Authors:  Stacy P Ardoin; David S Pisetsky
Journal:  Mod Rheumatol       Date:  2008-04-17       Impact factor: 3.023

Review 10.  The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles.

Authors:  Justyna Rosińska; Maria Łukasik; Wojciech Kozubski
Journal:  Cardiovasc Drugs Ther       Date:  2017-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.